Solventum (SOLV)

• Market cap: $12.7B
• 1 day: 1.13%
• 5 days: 10.09%
• 1 month: 7.16%
• 3 months: 1.52%
• 6 months: 38.70%
• Year to date: 11.50%
• 1 year: -8.11%
• 5 years: -8.11%
• 10 years: -8.11%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.

Employees: 22,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

43% more first-time investments, than exits

New positions opened: 146 | Existing positions closed: 102

29% more capital invested

Capital invested by funds: $5.68B [Q2] → $7.35B (+$1.67B) [Q3]

22% more funds holding in top 10

Funds holding in top 10: 9 [Q2] → 11 (+2) [Q3]

3% more funds holding

Funds holding: 887 [Q2] → 917 (+30) [Q3]

1.37% less ownership

Funds ownership: 62.22% [Q2] → 60.85% (-1.37%) [Q3]

26% less call options, than puts

Call options by funds: $48M | Put options by funds: $64.8M

59% less repeat investments, than reductions

Existing positions increased: 173 | Existing positions reduced: 427

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $70 5% downside
• Avg. target: $73 1% downside
• High target: $75 2% upside

3 analyst ratings

• positive: 0 0%
• neutral: 3 100%
• negative: 0 0%

Mizuho Steven Valiquette 20% 1-year accuracy 1 / 5 met price target	5% downside $70	Neutral Initiated	4 Dec 2024
Morgan Stanley Patrick Wood 55% 1-year accuracy 6 / 11 met price target	1% downside $73	Equal-Weight Maintained	11 Nov 2024
Piper Sandler Jason Bednar 37% 1-year accuracy 13 / 35 met price target	2% upside $75	Neutral Maintained	8 Nov 2024